RemedyBio logo — Remedy is creating a revolution in immune therapeutics thoug...

RemedyBio

Remedy is creating a revolution in immune therapeutics though cell-by-cell analysis of immune and disease biology

Founded 2017 Ireland Ireland 7 employees Series Unknown Total: $10.50M Biotechnology, Health and Wellness

General Information

Company Name RemedyBio
Founded Year 2017
Location Ireland Ireland +1
Founders / Decision Makers
Future Resourcing Clinical Research Galligan — CMO and Co-Founder
Employees 7
Industries Biotechnology, Health and Wellness
Funding Stage Series Unknown
Social

Get notified when RemedyBio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About RemedyBio

RemedyBio is a Dublin-based biotech company leveraging nanoscale technology to revolutionize immune therapeutics. Specializing in immuno-oncology, autoimmune diseases, and infectious diseases, the company's innovative approach involves the analysis of 10M-1Bn cells individually, significantly advancing single-cell research. Conducting combinational biology at scale, RemedyBio simultaneously analyzes healthy tissue, disease biology, and immunological function, providing a comprehensive understanding of diseases. Their advanced methodology involves statistical and machine analysis of millions or billions of cells, including those from patient tumor biopsies. Additionally, RemedyBio offers services for therapeutic design and long-term asset building, including sequencing, replicating, and banking post-assay biology. Established in 2017, the company recently secured a significant €8.00M Venture Round investment from The European Innovation Council on 20 July 2021.

Taxonomy: biotech, nanoscale technology, therapeutic research, immuno-oncology, autoimmune diseases, infectious diseases, cell analysis, immune system, diagnostic research, single-cell research, combinational biology, immunological function, therapeutic design, immune therapeutics, Dublin

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round €8.00M 1 20 Jul 2021
Grant €2.50M 1 01 Jun 2020

RemedyBio Alternatives & Competitors

RemedyBio vs

Biotech firm developing thymic cell therapies to restore immune function using machine learning

Seed
26 employees
Biotechnology, Health and Wellness
RemedyBio vs
Immusoft
Immusoft United States

Cell therapy company dedicated to improving the lives of patients with rare diseases

Grant
22 employees
Biotechnology, Health Care
RemedyBio vs

Pioneering tools for advancing stem cell research and developing vital diagnostics and treatments fo...

Series Unknown
Biotechnology, Health Care

FAQ About RemedyBio

Remedy is creating a revolution in immune therapeutics though cell-by-cell analysis of immune and disease biology
RemedyBio was founded in 2017.
RemedyBio is headquartered in Ireland.
RemedyBio operates in the following industries: Biotechnology, Health and Wellness.
RemedyBio has approximately 7 employees.
RemedyBio has completed 2 funding rounds, raising a total of $10.50M. The latest funding stage is Series Unknown.
Top alternatives and competitors to RemedyBio include Thymmune Therapeutics, Immusoft, ReInnervate, AbolerIS Pharma, Cogen Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
RemedyBio and Thymmune Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors RemedyBio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy